文献速递产科

可疑子痫前期孕妇按孕周特异性 sFlt-1 与 PlGF 阈值分层的妊娠与围产结局

Pregnancy and perinatal outcomes stratified by soluble fms-like tyrosine kinase-1 and placental growth factor gestation-specific thresholds in women with suspected preeclampsia.
PubMed 文献 · Am J Obstet Gynecol · 2026-02-24

该单中心回顾性研究纳入 457 例可疑子痫前期单胎妊娠,按孕周校正的 sFlt-1>第 95 百分位和 PlGF<第 5 百分位分为四组。结果显示不同血管生成表型具有显著不同的母胎结局。sFlt-1 升高主要与母体严重疾病相关,PlGF 降低主要与胎儿生长受限、死产和新生儿重症监护等不良胎儿结局相关。

要点

  • sFlt-1 升高主要提示母体严重疾病,如血小板降低、肌酐升高和尿蛋白升高。
  • PlGF 降低主要提示胎儿不良结局,包括小于胎龄儿、死产和 NICU 入院。
  • 联合 sFlt-1 与 PlGF 孕周特异性阈值可区分不同临床表型。

核心结论

  • 按孕周特异性 sFlt-1 和 PlGF 阈值对可疑子痫前期孕妇分层,可识别具有显著不同临床结局的母胎表型。
  • sFlt-1 升高与母体严重疾病密切相关,PlGF 降低与生长受限、死产和延长 NICU 住院等胎儿不良结局相关。

研究设计与样本

  • 英国三级转诊中心回顾性单中心研究,纳入 457 例可疑子痫前期单胎妊娠。
  • 使用孕周校正的 sFlt-1>第 95 百分位和 PlGF<第 5 百分位定义四组。
  • 连续变量采用 Kruskal-Wallis 检验或单因素方差分析,分类变量采用卡方或 Fisher 精确检验,双侧 P<0.05 为有统计学意义。

主要发现

  • 第 1 组(sFlt-1>第 95 百分位且 PlGF<第 5 百分位)100 例,第 2 组(sFlt-1>第 95 百分位且 PlGF>第 5 百分位)58 例,第 3 组(sFlt-1<第 95 百分位且 PlGF<第 5 百分位)31 例,对照组 268 例。
  • 与对照组相比,PlGF 降低的第 1 组和第 3 组早孕期 PAPP-A 均值显著更低,分别为 0.6(95%CI 0.6-0.7)和 0.5(95%CI 0.4-7.0),对照为 0.9(95%CI 0.8-1.0),P<0.001。
  • 与对照组相比,第 1 组和第 3 组中孕期联合子宫动脉 Doppler 搏动指数显著更高,分别为 1.47(95%CI 1.35-1.59)和 1.31(95%CI 1.13-1.51),对照为 0.98(95%CI 0.93-1.02),P<0.001。
  • 与对照组相比,sFlt-1 升高的第 1 组和第 2 组平均血小板计数显著更低,分别为 182.8(95%CI 168-198.8)和 176.7(95%CI 160.4-194.6),对照为 212.5(95%CI 204.9-220.4),P<0.01。
  • 第 1 至第 3 组 37 周前子痫前期发生率分别为 78.0%、39.7%、31.3%,对照组为 6.7%,组间差异 P<0.001。

关键数值与推荐

  • 第 1 组和第 2 组较对照组的平均肌酐水平分别为 70.1(95%CI 65.2-75.4)和 70.1(95%CI 63.3-78.3),对照为 59.4(95%CI 57.7-61.2),P<0.01。
  • 第 1 组和第 2 组较对照组的平均尿蛋白肌酐比分别为 93(95%CI 68.7-126.1)和 58.9(95%CI 38.9-89.0),对照为 25.8(95%CI 22.2-29.9),P<0.01。
  • 第 1 组中位分娩孕周为 33.4 周(范围 29.2-35.7),出生体重百分位中位数为 0.26(范围 0.00-2.71)。
  • 死产仅发生在 PlGF 降低的第 1 组(5.3%,n=5)和第 3 组(6.9%,n=2)。

临床怎么用

  • 对可疑子痫前期孕妇联合解读 sFlt-1 和 PlGF,可帮助区分母体风险和胎儿风险主导的不同临床表型。
  • sFlt-1 升高者应加强对母体终末器官损害的监测,如血小板、肌酐和尿蛋白。
  • PlGF 降低者应加强对胎儿生长、胎儿监护和分娩时机的评估。

局限性

  • 回顾性单中心设计,可能存在选择偏倚和混杂因素。
  • 仅纳入有 sFlt-1/PlGF 比值数据的单胎妊娠,结果外推到其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate gestational age appropriate soluble fms-like tyrosine kinase-1 and placental growth factor concentrations in determining abnormal outcomes in women with suspected preeclampsia. STUDY DESIGN: Retrospective single-center study of 457 singleton pregnancies from a tertiary referral center in the United Kingdom. Four subgroups were defined using gestational age-adjusted thresholds for soluble fms-like tyrosine kinase-1 (>95th centile) and placental growth factor (<fifth centile). Continuous variables were assessed for normality; non-normally distributed data were analyzed using the Kruskal-Wallis test with Bonferroni-adjusted pairwise comparisons. Log-transformed biochemical, angiogenic, and ultrasound variables were analyzed using one-way analysis of variance (df=3) with Dunnett post hoc comparisons versus controls (df=1). Categorical variables were compared using chi-square or Fisher's exact tests with post hoc comparisons where appropriate. A two-tailed P value <0.05 was considered statistically significant. RESULTS: Amongst singleton pregnancies with available soluble fms-like tyrosine kinase-1/placental growth factor ratios, angiogenic profiling classified women into 4 groups. Group 1 (soluble fms-like tyrosine kinase-1>95th, PlGF <fifth; n=100), Group 2 (soluble fms-like tyrosine kinase-1>95th, placental growth factor >fifth; n=58), Group 3 (soluble fms-like tyrosine kinase-1<95th, placental growth factor <fifth; n=31), and controls (Group 4) (soluble fms-like tyrosine kinase-1<95th, placental growth factor >fifth; n=268). Distinct angiogenic and ultrasonographic profiles were observed between groups (one-way analysis of variance, F (3,453), P<0.001). On post hoc Dunnett's, when compared to controls, Groups 1 and 3 with low placental growth factor (<fifth centile) had a significantly lower mean first trimester pregnancy associated plasma protein-A (0.6, [95% CI 0.6-0.7] and 0.5, [0.4-7.0] vs 0.9 [0.8-1.0]; df=1, P<0.001) and higher second trimester combined uterine artery Doppler pulsatility index (1.47 [1.35-1.59] and 1.31 [1.13-1.51] vs 0.98 [0.93-1.02]; df=1, P<0.001). Markers of maternal end-organ involvement also demonstrated strong group-level differences (one-way analysis of variance, F(3,453), P<0.001). On post hoc Dunnett's, when compared to controls, Groups 1 and 2 (sFlt-1>95th centile) had a significantly lower mean platelet count (182.8 [168-198.8] and 176.7 [160.4-194.6] vs 212.5 [204.9-220.4]; df=1, P<0.01), higher mean creatinine levels (70.1 [65.2-75.4] and 70.1 [63.3-78.3] vs 59.4 [57.7-61.2]; df=1, P<0.01) and higher mean urine protein: creatinine ratios (93 [68.7-126.1] and 58.9 [38.9-89.0] vs 25.8 [22.2-29.9]; df=1, P<0.01). The incidence of preeclampsia occurring before 37 weeks was higher in Groups 1 to 3 when compared to the controls, occurring in 78.0%, 39.7%, 31.3%, and 6.7% of pregnancies, respectively (P<0.001). Adverse neonatal outcomes were clustered particularly in Group 1 which had the lowest median gestational age at birth (median 33.4 [29.2-35.7] and lowest birthweight centile (0.26 [0.00-2.71]. The incidence of small for gestational age infants and need for neonatal intensive care unit admission was significantly higher across Groups 1 to 3 when each of the groups was individually compared to the controls (P<0.001 for all). Stillbirths occurred only in Groups 1 (5.3%, n=5) and 3 (6.9%, n=2) which had low placental growth factor levels <fifth centile. CONCLUSION: Stratification of women with suspected preeclampsia using gestational age-specific thresholds for soluble fms-like tyrosine kinase-1 and placental growth factor can identify distinct maternal and fetal phenotypes with significantly different clinical outcomes. Elevated soluble fms-like tyrosine kinase-1 concentrations appear to be strongly associated with severe maternal disease, whilst low placental growth factor appears to correlate with adverse fetal and neonatal outcomes including growth restriction, stillbirth, and prolonged neonatal intensive care stay.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Creswell, Christodoulou, Chang, et al. Pregnancy and perinatal outcomes stratified by soluble fms-like tyrosine kinase-1 and placental growth factor gestation-specific thresholds in women with suspected preeclampsia. Am J Obstet Gynecol. 2026. PMID: 41740916. doi:10.1016/j.ajog.2026.02.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。